Isomorphic Labs raises $2.1 Billion to scale its AI drug design engine

Isomorphic Labs, an AI-first drug design and development company, announced it has raised $2.1 Billion in Series B funding. This latest round of investment will accelerate the companyʼs evolution from pioneering novel AI models to applying them at scale. The financing round is led by Thrive Capital,...